NRX Pharmaceuticals, Inc
NRx Pharmaceuticals, Inc., based in Wilmington, DE, is a clinical biopharmaceutical company dedicated to addressing the critical unmet needs of patients suffering from severe bipolar depression and post-traumatic stress disorder (PTSD), particularly in the context of suicidality. The company is pioneering innovative treatments, including NRX-101, the first oral medication in FDA trials for suicidal bipolar depression, aiming to transform mental health care.
With a focus on non-hallucinogenic, non-addictive, and non-neurotoxic therapies, NRx Pharmaceuticals leverages novel approaches targeting the NMDA receptor to develop potential breakthroughs for those facing life-threatening mental health challenges. The organization emphasizes hope through its ongoing clinical trials and a commitment to improving the lives of individuals affected by these serious conditions.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
